Life Sciences Times

Emulate Submits FDA Qualification Package for Human Liver-Chip

Takeda Reports Phase 3 Oveporexton Data Published in New England Journal of Medicine

Crossbow Therapeutics Doses First Patient in Phase 1 Trial of CBX-663

Revvity to Acquire Human Cell Design to Expand Metabolic Disease Drug Discovery Tools

Tortugas Neuroscience Appoints Jim Frates to Board of Directors

PhenoNet Completes Enrollment in Phase IIb ALS Trial of PHENOGENE-1A

NanoMosaic Joins Mass General Brigham-Led ARPA-H Program to Advance Genetic Medicine Manufacturing

Alpha-9 Oncology Doses First Patient in Phase 1 Trial of GRPR-Targeted Radiotherapies

OsteoCentric Technologies Names Jeffrey Zanni to Lead Oncology and Limb Restoration Business

Alzheon Reports Biomarker Findings for Oral Alzheimer’s Drug Valiltramiprosate